Targeting the Akt Kinase to Modulate Survival, Invasiveness and Drug Resistance of Cancer Cells

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|15|1923-1945

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.15, 2013-05, pp. : 1923-1945

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cells

By  

Current Medicinal Chemistry, Vol. 18, Iss. 18, 2011-06 ,pp. : 2715-2726

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Calmodulin in Reversing Multi Drug Resistance in Cancer Cells

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 12, 2006-12 ,pp. : 1383-1389

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting synuclein-γ to counteract drug resistance in cancer

By Singh Vinay K   Jia Zongchao  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 1, 2008-01 ,pp. : 59-68

Informa Healthcare

Access to resources Recommend Favorite

Cancer Stem Cells: The Emerging Challenge of Drug Targeting

By  

Current Medicinal Chemistry, Vol. 16, Iss. 4, 2009-02 ,pp. : 394-416

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Serine / Threonine Protein Kinase B / Akt and Cell-cycle Checkpoint Kinases for Treating Cancer

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 939-971

Bentham Science Publishers

Access to resources Recommend Favorite